Iron alters glutamate secretion by regulating cytosolic aconitase activity

American Journal of Physiology - Cell Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  McGahan, M Christine ^a   Harned, Jill ^a   Mukunnemkeril, Marilyn ^a   Goralska, Malgorzata ^a   Fleisher, Lloyd ^a   Ferrell, Jenny B ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Lens epithelial cells; Retinal pigment epithelial cells

Indexed keywords

ACONITATE HYDRATASE; CITRIC ACID; CYTOPLASM PROTEIN; GLUTAMIC ACID; IRON; ISOCITRIC ACID; MALIC ACID DERIVATIVE; NEUROTRANSMITTER; OXALOMALIC ACID; RILUZOLE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GLUTAMATERGIC SYSTEM; HUMAN; HUMAN CELL; IRON METABOLISM; LENS EPITHELIUM; NERVOUS SYSTEM; NEUROLOGIC DISEASE; NEUROTRANSMITTER RELEASE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DEGENERATION;

ACONITATE HYDRATASE; ANIMALS; CELLS, CULTURED; CITRIC ACID; CYTOSOL; DOGS; ENZYME ACTIVATION; GLUTAMATES; IRON; ISOCITRATES; MEMBRANE TRANSPORT PROTEINS; OXALATES; PIGMENT EPITHELIUM OF EYE; RILUZOLE; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

MAMMALIA;

EID: 17644377285     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00444.2004     Document Type: Article

References (62)

1. Aarts MM and Tymianski M. Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors. Biochem Pharmacol 66: 877-886, 2003.
2. Abe T, Ishiguro SI, Saito H, Kiyosawa M, and Tamai M. Partially deficient glutamate dehydrogenase activity and attenuated oscillatory potentials in patients with spinocerebellar degeneration. Invest Ophthalmol Vis Sci 33: 447-452, 1992.
3. Bartzokis G, Mintz J, Sultzer D, Marx P, Herzberg JS, Phelan CK, and Marder SR. In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol 15: 1129-1138, 1994.
4. Berenshtein E, Vaisman B, Goldberg-Langerman C, Kitrossky N, Konijn AM, and Chevion M. Roles of ferritin and iron in ischemic preconditioning of the heart. Mol Cell Biochem 234-235: 283-292, 2002.
5. Bridges CC, Kekuda R, Wang H, Prasad PD, Mehta P, Huang W, Smith SB, and Ganapathy V. Structure, function and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 42: 47-54, 2001.
6. Bridges RJ, Stanley MS, Anderson MW, Cotman CW, and Chamberlin AR. Conformationally defined neurotransmitter analogues: selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem 34: 717-725, 1991.
7. Chapman J and Zhou M. Microplate-based fluorometric methods for the enzymatic determination of L-glutamate: application in measuring L-glutamate in food samples. Anal Chim Acta 402: 47-52, 1999.
8. Chen JC, Hardy PA, Kucharczyk W, Caluberg M, Joshi JG, and Henkelman RM. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 14: 274-281, 1993.
9. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634, 1988.
10. Colon AD, Plaitakis A, Perakis A, Berl S, and Clarke DD. Purification and characterization of a soluble and a paniculate glutamate dehydrogenase from rat brain. J Neurochem 46: 1811-1819, 1986.
11. Cornett CR, Markesbery WR, and Ehmann WE. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19: 339-345, 1998.
12. Defoe DM, Matsumoto B, and Besharse JC. Reconstitution of the photoreceptor-pigment epithelium interface: L-glutamate stimulation of adhesive interactions and rod disc shedding after recombination of dissociated Xenopus laevis eyecups. Exp Eye Res 54: 903-911, 1992.
13. Double KL, Gerlach M, Youdim MB, and Riederer P. Impaired iron homeostasis in Parkinson's disease. J Neural Transm Suppl 60: 37-58, 2000.
14. Farber NB, Jiang XP, Heinkel C, and Nemmers B. Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity. Mol Psychiatry 7: 726-733, 2002.
15. Faucheux BA, Martin ME, Beaumont C, Hunot S, Hauw JJ, Agid Y, and Hirsch EC. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J Neurochem 83: 320-330, 2002.
16. Festa M, Colonna A, Pietropaolo C, and Ruffo A. Oxalomalate, a competitive inhibitor of aconitase, modulates the RNA-binding activity of iron-regulatory proteins. Biochem J 348: 315-320, 2000.
17. Fremeau RT Jr, Burman J, Qureshi T, Tran CH, Proctor J, Johnson J, Zhang J, Sulzer D, Copenhagen DR, Storm-Mathisen J, Reimer RJ, Chaudhry FA, and Edwards RH. The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci USA 99: 14488-14493, 2002.
18. Goralska M, Harned J, Fleisher LN, and McGahan MC. The effect of ascorbic acid and ferric ammonium citrate on iron uptake and storage in lens epithelial cells. Exp Eye Res 66: 687-697, 1998.
19. Greenberger LM and Besharse JC. Stimulation of photoreceptor disc shedding and pigment epithelial phagocytosis by glutamate, aspartate and other amino acids. J Comp Neurol. 239: 361-372, 1985.
20. Hahn P, Milam AH, and Dunaief JL. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch Ophthalmol 121: 1099-1105, 2003.
21. Haile DJ, Rouault TA, Harford JB, Kennedy MC, Blondin GA, Beinert H, and Klausner RD. Cellular regulation of the iron-responsive element binding protein: disassembly of the cubane iron-sulfur cluster results in high-affinity RNA binding. Proc Natl Acad Sci USA 89: 11735-11739, 1992.
22. Hallgren B and Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 3: 41-51, 1958.
23. Hallgren B and Sourander P. The non-haemin iron in the cerebral cortex in Alzheimer's disease. J Neurochem 5, 1960.
24. Hayashi M, Morimoto R, Yamamoto A, and Moriyama Y. Expression and localization of vesicular glutamate transporters in pancreatic islets, upper gastrointestinal tract and testis. J Histochem Cytochem 51: 1375-1390, 2003.
25. Hayashi M, Yamada H, Uehara S, Morimoto R, Muroyama A, Yatsushiro S, Takeda J, Yamamoto A, and Moriyama Y. Secretory-granule-mediated co-secretion of L-glutamate and glucagon triggers the glutamatergic chemical transmission in the islet of Langerhans. J Biol Chem 278: 1966-1974, 2003.
26. Hentze MW and Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide and oxidative stress. Proc Natl Acad Sci USA 93: 8175-8182, 1996.
27. Hertz L and Zielke HR. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci 27: 735-743, 2004.
28. Hioki H, Fujiyama F, Taki K, Tomioka R, Furuta T, Tamamaki N, and Kaneko T. Differential distribution of vesicular glutamate transporters in the rat cerebellar cortex. Neuroscience 117: 1-6, 2003.
29. Jaffrey SR, Cohen NA, Rouault TA, Klausner RD, and Snyder SH. The iron-responsive element binding protein: a target for synaptic actions of nitric oxide. Proc Natl Acad Sci USA 91: 12994-12998, 1994.
30. Jo SH, Lee SH, Chun HS, Lee SM, Koh HJ, Lee SE, Chun JS, Park JW, and Huh TL. Cellular defense against UVB-induced phototoxicity by cytosolic NADP-dependent isocitrate dehydrogenase. Biochem Biophys Res Commun 292: 542-549, 2002.
31. Kennedy MC, Mende-Mueller L, Blondin GA, and Beinert H. Purification and characterization of cytosolic aconitase from beef liver and its relationship to the iron-responsive element binding protein. Proc Natl Acad Sci USA 89: 11730-11734, 1992.
32. Kim HY, LaVaute T, Iwai K, Klausner RD, and Rouault TA. Identification of a conserved and functional iron-responsive element in the 5́-untranslated region of mammalian mitochondrial aconitase. J Biol Chem 271: 24226-24230, 1996.
33. Kitajima H, Shiomoto H, Osada K, and Yokogoshi H. Co-administration of proline and inorganic iron enhance the improvement of behavioral and hematological function of iron-deficient anemic rats. J Nutr Sci Vitaminol (Tokyo) 49: 7-12, 2003.
34. Klausner RD, Rouault TA, and Harford JB. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72: 19-28, 1993.
35. Koch HP, Kavanaugh MP, Esslinger CS, Zerangue N, Humphrey JM, Amara SG, Chamberlin AR, and Bridges RJ. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Mol Pharmacol 56: 1095-1104, 1999.
36. Lee SM, Koh HJ, Park DC, Song BJ, Huh TL, and Park JW. Cytosolic NADP-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 32: 1185-1196, 2002.
37. Lee WK, Shin S, Cho SS, and Park JS. Purification and characterization of glutamate dehydrogenase as another isoprotein binding to the membrane of rough endoplasmic reticulum. J Cell Biochem 76: 244-253, 1999.
38. Link G, Pinson A, and Hershko C. Heart cells in culture: a model of myocardial iron overload and chelation. J Lab Clin Med 106: 147-153, 1985.
39. Lopez-Colome AM, Fragoso G, Wright CE, and Sturman JA. Excitatory amino acid receptors in membranes from cultured human retinal pigment epithelium. Curr Eye Res 13: 533-560, 1994.
40. Low SH, Marmorstein LY, Miura M, Li X, Kudo N, Marmorstein AD, and Weimbs T. Retinal pigment epithelial cells exhibit unique expression and localization of plasma membrane syntaxins which may contribute to their trafficking phenotype. J Cell Sci 115: 4545-4553, 2002.
41. Mäenpää H, Mannerström M, Toimela T, Salminen L, Saransaari P, and Tähti H. Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells. Pharmacol Toxicol 91: 116-122, 2002.
42. Marc RE and Cameron D. A molecular phenotype atlas of the zebrafish retina. J Neurocytol 30: 593-654, 2001.
43. McGahan MC and Fleisher LN. Inflammation-induced changes in the iron concentration and total iron-binding capacity of the intraocular fluids of rabbits. Graefes Arch Clin Exp Ophthalmol 226: 27-30, 1988.
44. McLellan GJ and Bedford PGC. The cytoskeletal intermediate filaments of canine retinal pigment epithelial cells in vivo and in vitro. Res Vet Sci 63: 245-251, 1997.
45. Minich T, Yokota S, and Dringen R. Cytosolic and mitochondrial isoforms of NADP-dependent isocitrate dehydrogenases are expressed in cultured rat neurons, astrocytes, oligodendrocytes and microglial cells. J Neurochem 86: 605-614, 2003.
46. Missirlis F, Hu J, Kirby K, Hilliker AJ, Rouault TA, and Phillips JP. Compartment-specific protection of iron-sulfur proteins by superoxide dismutase. J Biol Chem 278: 47365-47369, 2003.
47. Miyamoto K and Del Monte M. A Na-dependent glutamate transporter in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 35: 3589-3598, 1994.
48. Montana V, Ni Y, Sunjara V, Hua X, and Parpura V. Vesicular glutamate transporter-dependent glutamate release from astrocytes. J Neurosci 24: 2633-2642, 2004.
49. Morimoto R, Hayashi M, Yatsushiro S, Otsuka M, Yamamoto A, and Moriyama Y. Co-expression of vesicular glutamate transporters (VGLUT1 and VGLUT2) and their associated with synaptic-like microvesicles in rat pinealocytes. J Neurochem 84: 382-391, 2003.
50. Moriyama Y, Hayashi M, Yamada H, Yatsushito S, Ishio S, and Yamamoto A. Synaptic-like microvesicles, synaptic vesicle counterparts in endocrine cells, are involved in a novel regulatory mechanisms for hormonal synthesis and secretion. J Exp Biol 203: 117-125, 2000.
51. Narahari J, Ma R, Wang M, and Walden WE. The aconitase function of iron regulatory protein 1: genetic studies in yeast implicate its role in iron-mediated redox regulation. J Biol Chem 275: 16227-16234, 2000.
52. Nicholls D and Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci 11: 462-468, 1990.
53. Ogur M, Coker L, and Ogur S. Glutamate auxotrophs in Saccharomyces 1: I. The biochemical lesion in the glt-1 mutants-2. Biochem Biophys Res Commun 14: 193-197, 1964.
54. Olney JW. The toxic effects of glutamate and related compounds in the retina and the brain. Retina 2: 341-359, 1982.
55. Phillis JW and O'Regan MH. Characterization of modes of release of amino acids in the ischemic/reperfused rat cerebral cortex. Neurochem Int 43: 461-467, 2003.
56. Plaitakis A, Spanaki C, Mastorodemos V, and Zaganas I. Study of structure-function relationships in human glutamate dehydrogenases reveals novel molecular mechanisms for the regulation of the nerve tissue-specific (GLUD2) isoenzyme. Neurochem Int 43: 401-410, 2003.
57. Rajas F, Gire V, and Rousset B. Involvement of a membrane-bound form of glutamated dehydrogenase in the association of lysosomes to microtubules. J Biol Chem 271: 29882-29890, 1996.
58. Uchida N, Kiuchi Y, Miyamoto K, Uchida J, Tobe T, Tomita M, Shioda S, Nakai Y, Koide R, and Oguchi K. Glutamate-stimulated proliferation of rat retinal pigment epithelial cells. Eur J Pharmacol 343: 265-273, 1998.
59. Veuthey AL, Tsacopoulos M, Millan de Ruiz L, and Perrottet P. Cellular and subcellular localization of hexokinase, glutamate dehydrogenase, and alanine aminotransferase in the honeybee drone retina. J Neurochem 62: 1939-1946, 1994.
60. Yang JH and Park JW. Oxalomalate, a competitive inhibitor of NADP-dependent isocitrate dehydrogenase, enhances lipid peroxidation-mediated oxidative damage in U937 cells. Arch Biochem Biophys 416: 31-37, 2003.
61. Yefimova MG, Jeanny JC, Keller N, Sergeant C, Guillonneau X, Beaumont C, and Courtois Y. Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 43: 537-545, 2002.
62. Zecca L, Youdim MBH, Riederer P, Connor JR, and Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863-873, 2004.